Medicines with the highest expenditure in the Netherlands 2022
In 2022, rivaroxaban, also sold under the brand name Xarelto and used to treat deep vein thrombosis and pulmonary embolism, was the medicine with the second highest expenditure in the Netherlands. The expenditure for this drug amounted to 121 million euros.